BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14507318)

  • 1. Different immunophenotypes in Buerger's disease.
    Kurata A; Machinami R; Schulz A; Fukayama M; Franke FE
    Pathol Int; 2003 Sep; 53(9):608-15. PubMed ID: 14507318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboangiitis obliterans: classic and new morphological features.
    Kurata A; Franke FE; Machinami R; Schulz A
    Virchows Arch; 2000 Jan; 436(1):59-67. PubMed ID: 10664163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans).
    Kobayashi M; Ito M; Nakagawa A; Nishikimi N; Nimura Y
    J Vasc Surg; 1999 Mar; 29(3):451-8. PubMed ID: 10069909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboangiitis obliterans with multiple large vessel involvement: case report and analysis of immunophenotypes.
    Edo N; Miyai K; Ogata S; Nakanishi K; Hiroi S; Tominaga S; Aiko S; Kawai T
    Cardiovasc Pathol; 2010; 19(1):59-62. PubMed ID: 19135391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of thromboangiitis obliterans--a pathological contribution.
    Kurata A; Schulz A; Franke FE
    Verh Dtsch Ges Pathol; 2004; 88():231-6. PubMed ID: 16892557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of Notch signaling in the pathogenesis of Buerger's disease.
    Tamai H; Kobayashi M; Takeshita K; Kodama A; Banno H; Narita H; Yamamoto K; Komori K
    Surg Today; 2014 Feb; 44(2):307-13. PubMed ID: 23605216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and morphological aspects of Buerger's disease.
    Majewski W; Marszalek A; Staniszewiski R; Majewski P; Zapalski S; Biczysko W
    Int Angiol; 1997 Dec; 16(4):239-44. PubMed ID: 9543220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans.
    Idei N; Nishioka K; Soga J; Hidaka T; Hata T; Fujii Y; Fujimura N; Maruhashi T; Mikami S; Teragawa H; Kihara Y; Noma K; Chayama K; Higashi Y
    Hypertension; 2011 Jan; 57(1):70-8. PubMed ID: 21115876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of occlusive peripheral vascular disease in India. (clinicopathological study of 79 cases).
    Kinare SG; Kher YR; Rao G; Sen PK
    Angiology; 1976 Mar; 27(3):165-80. PubMed ID: 1078312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical properties in the patients with Buerger's disease--possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture.
    Sato T; Tamai H; Kobayashi M; Yamamoto K; Komori K
    Cardiovasc Pathol; 2011; 20(5):266-71. PubMed ID: 20708412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiologic analysis of arterial tissue in Buerger's disease.
    Lee T; Seo JW; Sumpio BE; Kim SJ
    Eur J Vasc Endovasc Surg; 2003 May; 25(5):451-7. PubMed ID: 12713785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
    Papa M; Bass A; Adar R; Halperin Z; Schneiderman J; Becker CG; Brautbar H; Mozes E
    Surgery; 1992 May; 111(5):527-31. PubMed ID: 1598672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcirculatory characteristics in patients with Buerger's disease.
    Nishikimi N; Sakurai T; Shionoya S; Oshima M
    Angiology; 1992 Apr; 43(4):312-9. PubMed ID: 1558316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current pathological and clinical aspects of Buerger's disease in Japan.
    Kobayashi M; Nishikimi N; Komori K
    Ann Vasc Surg; 2006 Jan; 20(1):148-56. PubMed ID: 16378138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of autoimmunity in thromboangiitis obliterans (Buerger's disease).
    Ketha SS; Cooper LT
    Ann N Y Acad Sci; 2013 May; 1285():15-25. PubMed ID: 23510296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease).
    Lie JT
    Acta Pathol Jpn; 1989 Mar; 39(3):153-8. PubMed ID: 2662703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endarteritis obliterans in the pathogenesis of Buerger's disease from the pathological and immunohistochemical points of view.
    Kobayashi M; Sugimoto M; Komori K
    Circ J; 2014; 78(12):2819-26. PubMed ID: 25298073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic change of the internal elastic lamina in Buerger's disease.
    Kim EJ; Cho BS; Lee TS; Kim SJ; Seo JW
    J Korean Med Sci; 2000 Feb; 15(1):44-8. PubMed ID: 10719807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviation of A disintegrin and metalloprotease 10 (ADAM10) on thromboangiitis obliterans involves the HMGB1/RAGE/ NF-κB pathway.
    Liu C; Kong X; Wu X; Wang X; Guan H; Wang H; Wang L; Jin X; Yuan H
    Biochem Biophys Res Commun; 2018 Oct; 505(1):282-289. PubMed ID: 30245136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid metabolism of the arterial wall in thromboangiitis obliterans (Buerger's disease).
    Horsch AK
    Virchows Arch A Pathol Anat Histol; 1975 Dec; 369(2):123-30. PubMed ID: 814703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.